Research and Clinical Trials

Carle Cancer Center has conducted cancer research for more than 20 years, giving patients access to innovative treatment options. In 1983, it was one of the first community cancer facilities in the U.S. to be designated a Community Clinical Oncology Program (CCOP), directly linking Carle Cancer Center with the National Cancer Institute’s research endeavors.

Carle Cancer Center participates in more than 100 research studies, including National Institutes of Health-funded and pharmaceutical-sponsored studies for the potential prevention, control and treatment of cancer.

The American Society of Clinical Oncology and the National Institutes of Health have recently recognized Carle Cancer Center for its significant contribution to clinical research. Read about the awards.

Carle Cancer Center's primary research affiliation is with North Central Cancer Treatment Group (NCCTG), led by Mayo Clinic in Rochester, Minn. The Center also participates in the following national research programs:

Cancer Trials Support Unit (CTSU), a pilot project sponsored by the National Cancer Institute to facilitate access to a large grouping of nationally recognized clinical trials
Eastern Cooperative Oncology Group (ECOG), one of the leading providers of hematology clinical trials
Gynecologic Oncology Group (GOG), a major contributor to new ideas for prevention and management of female pelvic malignancies
National Surgical Adjuvant Breast and Bowel Project (NSABP), a landmark developer of breast cancer prevention trials
Radiation Therapy Oncology Group (RTOG), a National Cancer Institute-funded organization offering clinical trials involving radiation therapy

For more information or to speak with a patient advocate,
call Cancer Research and Prevention Department at (217) 383-3516
or (800) 446-5532.

Trial information is available for research professionals.

Privacy Statement | Site Map | Webmaster